Article
Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance
3 Dec 2018
Abstract excerpt
BACKGROUND: Inherent or acquired chemo resistance in cancer patients has been a perpetual limitation in cancer treatment. Expanding knowledge on essential cellular processes opens a new window for therapeutic targeting. Ribosome biogenesis is a process that shows potential due to its fundamental role in cell development and contribution to tumorigenesis as a result of its upregulation. Inhibiting components of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
